Generalized Anxiety Disorder (GAD): Symptoms, Causes and All Treatment Options
- Dr. Kimryn Rathmell
- 5 days ago
- 8 min read
Anxiety is a normal part of human experience — a useful alarm system that prepares us to respond to threats. But when anxiety becomes persistent, excessive, difficult to control, and starts interfering with everyday life without any specific trigger, it may be Generalized Anxiety Disorder (GAD).
GAD is one of the most common mental health conditions in the United States, affecting approximately 6.8 million adults — about 3.1% of the population — in any given year. Despite being so prevalent, it is chronically underdiagnosed and undertreated, with many people living with its symptoms for years before receiving a correct diagnosis and effective treatment.
The good news is that GAD is one of the most treatable anxiety disorders. With the right combination of psychological therapy and, where appropriate, medication — including specific medicines with strong evidence for GAD — the majority of patients achieve meaningful reduction in symptoms and significant improvement in quality of life.
According to the National Institute of Mental Health (NIMH), GAD is characterised by persistent, excessive worry that is difficult to control and occurs more days than not for at least 6 months. Full diagnostic criteria and treatment information are available at: https://www.nimh.nih.gov/health/topics/generalized-anxiety-disorder-gad
What is Generalized Anxiety Disorder?
GAD is a chronic anxiety disorder characterised by pervasive, uncontrollable worry about a wide range of everyday topics — health, finances, work, family, world events — out of proportion to the actual likelihood or impact of the feared outcomes.
Unlike phobias or panic disorder, which involve intense anxiety in response to specific triggers, GAD involves a generalised state of worry and tension that is present most of the time and spans multiple areas of life. People with GAD often describe themselves as "worriers" — but the key distinction is that GAD-level worry is difficult to control, causes significant distress, and is associated with physical symptoms that affect daily functioning.
GAD is more than just being a "nervous person." It is a diagnosable neurobiological condition involving dysregulation of the brain's fear and threat-detection systems, altered activity in the amygdala and prefrontal cortex, and changes in neurotransmitter systems including serotonin, norepinephrine, and GABA.
Symptoms of GAD
The DSM-5 diagnostic criteria for GAD include persistent excessive anxiety and worry for at least 6 months, plus at least 3 of the following physical and psychological symptoms:
Psychological symptoms:
Excessive, difficult-to-control worry about multiple topics
Feeling on edge, keyed up, or restless
Difficulty concentrating — mind going blank
Irritability
Physical symptoms:
Muscle tension or muscle aches
Fatigue — often profound, disproportionate to activity
Sleep disturbance — difficulty falling asleep, staying asleep, or non-restorative sleep
Headaches
Gastrointestinal symptoms — nausea, diarrhoea, irritable bowel (GAD and IBS frequently co-occur)
Trembling or twitching
Sweating, palpitations
The key functional criterion:
Symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
What Causes GAD?
GAD results from a combination of genetic, neurobiological, and environmental factors:
Genetic factors:
GAD runs in families — having a first-degree relative with GAD approximately doubles the risk. Twin studies suggest that genetic factors account for approximately 30–40% of GAD susceptibility.
Neurobiological factors:
GAD involves dysregulation of neurotransmitter systems — particularly GABA (the brain's primary inhibitory neurotransmitter), serotonin, and norepinephrine. Abnormal activity in the amygdala (the brain's threat-detection centre) and reduced prefrontal cortex regulation of the amygdala are consistently observed on neuroimaging of GAD patients.
Psychological factors:
Certain cognitive patterns — tendency towards threat overestimation, intolerance of uncertainty, and worry as a coping mechanism — are strongly associated with GAD development and maintenance.
Life experiences:
Trauma, prolonged stress, childhood adversity, and significant life transitions (job loss, relationship breakdown, health diagnoses) can trigger or worsen GAD in vulnerable individuals.
Medical conditions:
Several medical conditions can cause or worsen anxiety symptoms, including thyroid disorders (hyperthyroidism), cardiovascular conditions, and chronic pain conditions such as fibromyalgia. If you have fibromyalgia, our guide explores the anxiety-pain connection in detail: https://www.themedicinekart.com/post/fibromyalgia-symptoms-causes-treatment-guide
GAD vs Normal Anxiety — How to Tell the Difference
Feature | Normal Anxiety | Generalized Anxiety Disorder (GAD) |
Trigger | Usually linked to a specific, identifiable event or stressor | Worry involves multiple topics and may occur without a clear trigger |
Duration | Typically improves when the situation resolves | Persists for 6 months or longer, occurring on most days |
Controllability | Usually manageable with conscious effort | Difficult to control despite attempts to stop worrying |
Intensity | Generally proportionate to the situation | Excessive or disproportionate to the actual level of risk |
Physical Symptoms | Mild and temporary | Persistent symptoms such as muscle tension, fatigue, restlessness, and sleep disturbance |
Impact on Daily Functioning | Little or no impairment | Causes clinically significant impairment in work, school, relationships, or daily activities |
Worrying About Worrying | Uncommon | Common; people often become concerned about their ongoing anxiety itself |
Diagnosing GAD
GAD is diagnosed clinically by a psychiatrist, psychologist, or trained primary care physician based on DSM-5 criteria. There is no blood test or brain scan for GAD. However, blood tests are useful to rule out medical causes of anxiety symptoms — particularly thyroid function (TSH, free T4), as hyperthyroidism can produce anxiety symptoms indistinguishable from GAD.
The GAD-7 questionnaire is a widely used, validated 7-item screening tool used in clinical practice to assess GAD severity. Scores range from 0 to 21:
GAD-7 Score | Anxiety Severity |
0–4 | Minimal anxiety |
5–9 | Mild anxiety |
10–14 | Moderate anxiety |
15–21 | Severe anxiety |
A score of 10 or above on the GAD-7 is used as a threshold for further evaluation. The tool is widely endorsed by the American Psychiatric Association and is available through most primary care practices.
Treatment Options for GAD
GAD treatment follows an evidence-based stepped-care model — starting with the least intensive interventions and stepping up as needed. Most patients achieve significant improvement with a combination of psychological therapy and medication.
1. Psychotherapy — CBT is Gold Standard
Cognitive Behavioural Therapy (CBT) is the most evidence-based psychological treatment for GAD, with response rates of 50–60% in clinical trials. CBT for GAD specifically targets:
Worry postponement and scheduled worry time
Cognitive restructuring — challenging overestimation of threat probability and severity
Intolerance of uncertainty — the core maintaining mechanism of GAD
Relaxation training and mindfulness
Behavioural experiments to test worry predictions against reality
The American Psychological Association provides a comprehensive overview of evidence-based anxiety treatments at: https://www.apa.org/topics/anxiety
CBT is typically delivered in 12–20 weekly sessions and produces durable improvements that persist after therapy ends — unlike medication, whose effects are largely limited to the period of active treatment.
2. Pregabalin (Lyrica) — FDA-Approved for GAD
Pregabalin is one of the most important pharmacological options for GAD and one of the few medicines with a specific FDA approval for this indication. It works by binding to alpha-2-delta subunits of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters (glutamate, norepinephrine, substance P) that drive anxiety.
Clinical trials have demonstrated that Pregabalin produces significant reductions in both psychological and physical symptoms of GAD compared to placebo, with response rates comparable to benzodiazepines but without their dependency risk.
Key advantages of Pregabalin for GAD:
Effective for both psychological worry and physical symptoms (muscle tension, sleep disturbance, fatigue)
Faster onset than SSRIs/SNRIs (typically 1–2 weeks vs 4–6 weeks)
No dependence risk comparable to benzodiazepines
Safe for long-term use
Typical dose: 150–600mg per day in two to three divided doses.
At TheMedicineKart, we stock generic [Pregabalin 300mg tablets] at significant savings off branded Lyrica. For full dosage and safety information, see our complete [Pregabalin Guide].
3. SSRIs and SNRIs — First-Line Antidepressants
SSRIs (sertraline, escitalopram, paroxetine) and SNRIs (venlafaxine, duloxetine) are considered first-line pharmacological treatments for GAD in most guidelines. They work by increasing serotonin and/or norepinephrine availability, modulating the anxiety circuits involved in GAD.
Onset of effect takes 4–6 weeks. Initial side effects (nausea, insomnia, jitteriness) usually resolve in the first 1–2 weeks. Long-term treatment (12 months or more) is typically recommended to prevent relapse.
4. Buspirone
A non-benzodiazepine anxiolytic that acts on serotonin (5-HT1A) receptors. Less sedating than benzodiazepines, no dependency risk, but slower onset (2–4 weeks). A useful option for patients who cannot tolerate SSRIs or who wish to avoid sedating medicines.
5. Benzodiazepines — Short-Term Use Only
Benzodiazepines (diazepam, lorazepam, clonazepam) provide rapid, effective symptom relief but are associated with tolerance, dependence, and withdrawal with regular use. Current guidelines limit their use to short-term management of acute anxiety while awaiting the effect of longer-term treatments — they are not recommended for ongoing GAD management.
6. Lifestyle and Self-Management
Evidence consistently supports several lifestyle interventions as meaningful adjuncts to formal treatment:
Regular aerobic exercise
multiple studies show 30+ minutes of aerobic exercise 3–5 times per week reduces anxiety symptoms comparably to medication in mild-to-moderate GAD
Sleep hygiene
GAD and poor sleep are tightly linked; improving sleep quality reduces anxiety. See our complete guide on insomnia causes and management: https://www.themedicinekart.com/post/what-causes-insomnia-10-reasons-cant-sleep
Caffeine reduction
caffeine directly increases cortisol and adrenaline, worsening anxiety symptoms; reducing intake is one of the most immediately effective self-management steps
Mindfulness-based stress reduction (MBSR)
well-evidenced for anxiety reduction
Limiting alcohol
while alcohol provides short-term anxiolytic relief, it worsens anxiety in the medium and long term through rebound effects and disruption of sleep architecture
GAD and Common Co-occurring Conditions
GAD rarely occurs in isolation. It commonly co-exists with:
Major depressive disorder (50–60% of GAD patients have comorbid depression)
Other anxiety disorders (panic disorder, social anxiety, specific phobias)
Insomnia — often both a symptom and a maintaining factor for GAD
Chronic pain conditions — including fibromyalgia and chronic back pain
Effective GAD treatment often improves these co-occurring conditions simultaneously, particularly when Pregabalin is used — which addresses anxiety, sleep, and pain components together.
Frequently Asked Questions
What is the difference between GAD and an anxiety attack?
GAD involves persistent, chronic background anxiety and worry present most days over at least 6 months. An anxiety or panic attack is a discrete, acute episode of intense fear or discomfort that peaks within minutes and then subsides. Many people with GAD also experience panic attacks, but the two are distinct — GAD is about ongoing worry, panic attacks are episodic events.
How long does GAD treatment take to work?
CBT typically shows meaningful improvement within 6 to 12 sessions. SSRIs and SNRIs take 4 to 6 weeks to reach full effect. Pregabalin typically shows benefit within 1 to 2 weeks. Buspirone takes 2 to 4 weeks. Most guidelines recommend 12 months of medication treatment after symptom remission before discussing dose reduction.
Is Pregabalin addictive?
Pregabalin has a lower dependence risk than benzodiazepines. However, it should be tapered rather than stopped abruptly after prolonged use to avoid withdrawal symptoms including insomnia, nausea, and headache. It is classified as a Schedule V controlled substance in the USA, reflecting a low but real misuse potential, and requires a valid prescription.
Can GAD go away without treatment?
GAD tends to be chronic and episodic — periods of worsening alternating with periods of partial improvement. Spontaneous full remission without any intervention is uncommon. With appropriate treatment, the majority of patients achieve significant symptom reduction and many achieve full remission.
Is GAD different from stress?
Yes. Stress is a normal response to external pressures that typically resolves when the stressor resolves. GAD is a persistent anxiety disorder that continues even when there is nothing specific to worry about, involves worry that is disproportionate and difficult to control, and produces physical symptoms affecting daily functioning over months.
Comments